Kite, a Gilead Company (Nasdaq: GILD), today announces findings from the largest real-world analysis to date of Tecartus® (brexucabtagene autoleucel) in patients with relapsed or...
Gilead Sciences, Inc. (Nasdaq: NASDAQ:GILD) today announced longer-term overall survival (OS) results from the Phase 3 TROPiCS-02 study evaluating Trodelvy® (sacituzumab...
-- Yescarta Results in a 27.4% Reduction in Risk of Death, Corresponding to a 38% Relative Improvement in OS, Despite 57% of Patients Subsequently Receiving Cell Therapy Off...
Stagflation remains one of the primary risks for the global economy in 2023. The stock market’s trajectory will continue to be dictated by worries over persistently high...
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 7.79 | 7.89 | 7.60 | +0.03 | +0.39% | 62.85M | NYSE | |||
| 148.82 | 151.50 | 146.17 | +3.90 | +2.69% | 2.80M | NASDAQ | |||
| 45.65 | 48.00 | 45.49 | -1.86 | -3.92% | 437.75K | NYSE | |||
| 2.95 | 3.01 | 2.87 | +0.050 | +1.72% | 1.41M | NASDAQ | |||
| 0.003 | 0.003 | 0.003 | 0.00 | 0.00% | 0.00 | OTC Markets | |||
| 0.49 | 0.51 | 0.4632 | -0.0399 | -7.53% | 212.42K | NASDAQ | |||
| 24.23 | 26.09 | 17.63 | +8.70 | +56.02% | 173.09M | NYSE | |||
| 0.079 | 0.085 | 0.076 | 0.00 | +0.13% | 2.27M | NASDAQ | |||
| 92.53 | 92.68 | 91.30 | +0.01 | +0.01% | 8.98M | NYSE | |||
| 0.742 | 0.827 | 0.702 | -0.050 | -6.31% | 76.80K | NASDAQ | |||
| 122.67 | 123.73 | 122.01 | -0.27 | -0.22% | 24.29M | NASDAQ | |||
| 12.82 | 14.25 | 12.82 | +1.06 | +9.01% | 1.78M | NYSE | |||
| 4.11 | 4.17 | 3.97 | -0.05 | -1.20% | 7.51M | NYSE | |||
| 0.0001 | 0.0001 | 0.00 | +0.00010 | +1,000.00% | 89.96M | OTC Markets | |||
| 0.379 | 0.38 | 0.228 | +0.124 | +48.67% | 170.99K | OTC Markets |